Cargando…

POSB222 Can Gene Therapy Prices Remain the Same? What We Have Learned from the COVID-19 Vaccines

Detalles Bibliográficos
Autores principales:	Sigurðardóttir, K, Sola-Morales, O
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Inc. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8769576/ http://dx.doi.org/10.1016/j.jval.2021.11.716

Ejemplares similares

COVID-19 vaccine challenges: What have we learned so far and what remains to be done?
por: Forman, Rebecca, et al.
Publicado: (2021)

“You have not remained the same, nor have I”
por: Golwala, Zainab, et al.
Publicado: (2022)

Esophageal Mucosal Resistance in Reflux Esophagitis: What We Have Learned So Far and What Remains to Be Learned
por: Maev, Igor V., et al.
Publicado: (2023)

POSB193 COVID-19 Vaccine Development Pipeline: 2021
por: Ahlawat, R, et al.
Publicado: (2022)

POSB360 Perception of COVID-19 Vaccination Among Chronic Patients: To Be or Not to Be Vaccinated?
por: Vives, A, et al.
Publicado: (2022)

POSB223 Impact of the COVID-19 Pandemic on Influenza Vaccination Policies
por: Net, P, et al.
Publicado: (2022)

Violence against children in the time of COVID-19: What we have learned, what remains unknown and the opportunities that lie ahead
por: Fore, Henrietta H.
Publicado: (2021)

Implementation of HPV Tests in Latin America: What We Learned; What Should We Have Learned, and What Can We Do Better?
por: Godoy, Luani Rezende, et al.
Publicado: (2022)

Pneumococcal vaccination: what have we learnt so far and what can we expect in the future?
por: Torres, A., et al.
Publicado: (2014)

Trajectories of prices in generic drug markets: what can we infer from looking at trajectories rather than average prices?
por: Trujillo, Antonio J., et al.
Publicado: (2022)

What have we learned?
por: Rodgers, Peter, et al.
Publicado: (2021)

Reversal Agents: What We Have and What We Can Expect
por: Ruff, Christian T.
Publicado: (2018)

Two Decades of Research on Euthanasia from the Netherlands. What Have We Learnt and What Questions Remain?
por: Rietjens, Judith A. C., et al.
Publicado: (2009)

What Lessons Have We Learned and What Remains to be Clarified for PCSK9 Inhibitors? A Review of FOURIER and ODYSSEY Outcomes Trials
por: Furtado, Remo H. M., et al.
Publicado: (2020)

Erratum to: Pneumococcal vaccination: what have we learnt so far and what can we expect in the future?
por: Torres, A., et al.
Publicado: (2014)

EEG during the COVID-19 pandemic: What remains the same and what is different
por: Sethi, Nitin K.
Publicado: (2020)

Neutrinos, what we have learned about them and what we have learned using them
por: Steinberger, J
Publicado: (2013)

Medial Meniscus Posterior Root Tear: How Far Have We Come and What Remains?
por: Moon, Hyun-Soo, et al.
Publicado: (2023)

GOAL: What Have We Learned?
por: Leek, Timothy K Vander
Publicado: (2005)

What have we learned on mesons?
por: Moebes, J P
Publicado: (1972)

SARS: What have we learned?
Publicado: (2003)

What We Have Learned and What We Have Missed in Tuberculosis Pathophysiology for a New Vaccine Design: Searching for the “Pink Swan”
por: Cardona, Pere-Joan
Publicado: (2017)

Psychological Interventions for Dementia Caregivers: What We Have Achieved, What We Have Learned
por: Cheng, Sheung-Tak, et al.
Publicado: (2019)

Commentary: We are in the same minimally invasive boat, and we have to row in the same direction
por: Bertolaccini, Luca, et al.
Publicado: (2020)

INDIAN PSYCHIATRY AT THE CROSSROADS - WHAT WE CAN DO WITH WHAT WE HAVE?1
por: Channabasavanna, S.M.
Publicado: (1992)

HepCare Europe: a new user-friendly hepatitis C care service model. What have we learned? What are the remaining challenges?
por: Rockstroh, Jürgen Kurt, et al.
Publicado: (2019)

POSB255 Enough with the Madness! Hydroxychloroquine Is NOT a Treatment for COVID-19.
por: Santos, A, et al.
Publicado: (2022)

Lessons learned from COVID-19 for clinical research operations in Italy: what have we learned and what can we apply in the future?
por: Cagnazzo, Celeste, et al.
Publicado: (2020)

POSB266 NICE Published Oncology Recommendations: What Progress Has Been Made During the COVID-19 Era?
por: Samuels, E, et al.
Publicado: (2022)

What have we learned from LEP?
Publicado: (2001)

What have we learned from LEP?
Publicado: (2001)

What have we learned from LEP?
por: Ellis, Jonathan Richard
Publicado: (2001)

Genetics of Obesity: What have we Learned?
por: Choquet, Hélène, et al.
Publicado: (2011)

Higgs sector: What we have learned
por: Fiorini, Luca
Publicado: (2020)

Phage Therapy: What Have We Learned?
por: Górski, Andrzej, et al.
Publicado: (2018)

COVID-19: what have we learned?
por: Ho, Yeh-Li, et al.
Publicado: (2020)

Endometriosis and Reproduction: What We Have Learned
por: Garcia-Fernandez, Jaime, et al.
Publicado: (2020)

COVID-19: What have we learned?
por: Rafalowski, Chaim, et al.
Publicado: (2022)

Orthopaedic infections: what have we learned?
por: Lee, Christopher, et al.
Publicado: (2023)

Domestication and Breeding of Tomatoes: What have We Gained and What Can We Gain in the Future?
por: Bai, Yuling, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_1cuc6i1h5gms3vefjnd7gj7ien